Evidence map›Paper›PMID 39300173›Full record

ArticleNature structural & molecular biology2024

Publisher Correction: Structural basis of LRPPRC-SLIRP-dependent translation by the mitoribosome.

Vivek Singh, J Conor Moran, Yuzuru Itoh, Iliana C Soto, Flavia Fontanesi, Mary Couvillion, Martijn A Huynen, L Stirling Churchman, Antoni Barrientos, Alexey Amunts

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature structural & molecular biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Vivek Singh *Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Solna, Sweden.
J Conor Moran *Medical Scientist Training Program, Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL, USA.
Yuzuru ItohScience for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Solna, Sweden. yuzuru.itoh@bs.s.u-tokyo.ac.jp.
Iliana C SotoBlavatnik Institute, Department of Genetics, Harvard Medical School, Boston, MA, USA.
Flavia FontanesiMedical Scientist Training Program, Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL, USA.
Mary CouvillionBlavatnik Institute, Department of Genetics, Harvard Medical School, Boston, MA, USA.
Martijn A HuynenDepartment of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands.
L Stirling ChurchmanBlavatnik Institute, Department of Genetics, Harvard Medical School, Boston, MA, USA. churchman@genetics.med.harvard.edu.
Antoni BarrientosDepartment of Neurology, University of Miami Miller School of Medicine, Miami, FL, USA. abarrientos@med.miami.edu.
Alexey AmuntsScience for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Solna, Sweden. alexey.amunts@gmail.com.ORCID http://orcid.org/0000-0002-5302-1740

Funding

Mitochondrial mRNA structure as a driver of Leigh SyndromeF30HD107939 · NICHD · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI MORAN, JOHN CONOR · 2022 to 2025
$194k
NICHD NIH HHS F30 HD107939
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39300173
PMCPMC11564100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.